BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Yamamoto H, Umeda M, Mizoguchi H, Kato S, Takeuchi K. Protective effect of Irsogladine on monochloramine induced gastric mucosal lesions in rats: a comparative study with rebamipide. World J Gastroenterol 1999; 5(6): 477-482 [PMID: 11819495 DOI: 10.3748/wjg.v5.i6.477]
URL: https://www.wjgnet.com/1007-9327/full/v5/i6/477.htm
Number Citing Articles
1
Takashi Kyoi, Michiko Oka, Kumiko Noda, Yojiro Ukai. Irsogladine Prevents Monochloramine-Induced Gastric Mucosal Lesions by Improving the Decrease in Mucosal Blood Flow Due to the Disturbance of Nitric Oxide Synthesis in RatsJournal of Pharmacological Sciences 2003; 93(3): 314 doi: 10.1254/jphs.93.314
2
Tetsuro Hiratsuka, Seiji Futagami, Tomotaka Shindo, Tatsuhiko Hamamoto, Nobue Ueki, Kenji Suzuki, Yoko Shinji, Masanori Kusunoki, Kei Shinoki, Ken Wada, Kazumasa Miyake, Katya Gudis, Taku Tsukui, Choitsu Sakamoto. Rebamipide Reduces Indomethacin-Induced Gastric Injury in Mice via Down-Regulation of ICAM-1 ExpressionDigestive Diseases and Sciences 2005; 50(S1): S84 doi: 10.1007/s10620-005-2811-6
3
J Yao, Y Zhu, W Sun, N Sawada, N Hiramatsu, M Takeda, M Kitamura. Irsogladine maleate potentiates the effects of nitric oxide on activation of cAMP signalling pathways and suppression of mesangial cell mitogenesisBritish Journal of Pharmacology 2007; 151(4): 457 doi: 10.1038/sj.bjp.0707255
4
Yoshihiro Isomura, Yutaka Yamaji, Atsuo Yamada, Yoshitaka Watanabe, Hirobumi Suzuki, Yuka Kobayashi, Shuntaro Yoshida, Hirotsugu Watabe, Yoshihiro Hirata, Haruhiko Yoshida, Kazuhiko Koike. Irsogladine improves small-intestinal injuries in regular users of nonsteroidal anti-inflammatory drugsGastrointestinal Endoscopy 2014; 80(1): 118 doi: 10.1016/j.gie.2013.12.030
5
Li-Sheng Li, Rui-Yao Qu, Wei Wang, Hua Guo. Significance of changes of gastrointestinal peptides in blood and ileum of experimental spleen deficiency ratsWorld Journal of Gastroenterology 2003; 9(3): 553-556 doi: 10.3748/wjg.v9.i3.553